ICU Medical, Inc. (ICUI) Stock

ICU Medical, Inc., headquartered in San Clemente, California, is a global leader in the development, manufacturing, and distribution of medical devices essential for infusion therapy and critical care applications worldwide. The company's extensive product portfolio includes innovative infusion therapy solutions such as needlefree devices branded as MicroClave, MicroClave Clear, and NanoClave, as well as catheter patency devices like Neutron. ICU Medical also offers disinfecting caps (SwabCap and SwabTip), hemodialysis connectors (Tego), and antimicrobial barrier caps (ClearGuard HD) aimed at enhancing patient safety and infection control.

In addition to infusion therapy products, ICU Medical provides a comprehensive range of IV therapy solutions including sodium chloride, dextrose, balanced electrolyte solutions, and sterile water, catering to diverse medical needs in acute care settings. The company's offerings extend to critical care products such as hemodynamic monitoring systems (Cogent 2-in-1, CardioFlo), cardiac output monitoring catheters (TDQ, OptiQ), venous oximetry catheters (TriOx), and blood pressure transducers (Transpac). ICU Medical is also renowned for its SafeSet closed blood sampling and conservation systems, essential for maintaining sterile conditions and accurate blood sampling.

Founded in 1984, ICU Medical continues to innovate with advanced technologies that integrate seamlessly into hospital workflows. The company's commitment to patient safety and clinical efficacy is exemplified through its IV medication safety software, ICU Medical MedNet, which connects smart pumps to electronic health records, asset tracking systems, and alarm notification platforms. With a customer base spanning acute care hospitals, ambulatory clinics, outpatient facilities, and long-term care providers, ICU Medical remains dedicated to advancing healthcare delivery through reliable and cutting-edge medical solutions.